Long-Term Survival And Health-Related Quality Of Life With Nivolumab For Previously-Treated Advanced Non-Small Cell Lung Cancer (Nsclc): A Wide Prospective French Real-World Study (Evidens)

F. Barlesi,A. Dixmier,D. Debieuvre,C. Raspaud,J. B. Auliac, B. Nicolas,P. Bombaron,D. Moro-Sibilot,C. Audigier-Valette,B. Asselain, J. Dumanoir,F-E. Cotte,V. Allan, C. Calvet,D. Reynaud,M. Perol

ANNALS OF ONCOLOGY（2021）

引用 0|浏览2

暂无评分

摘要

EVIDENS is a prospective, observational and multicenter study of NSCLC patients treated with nivolumab after prior chemotherapy. Prior report showed consistent outcomes as compared with randomized clinical trials1. We report here long-term overall survival (OS) and health-related quality of life (HRQoL).

查看译文

关键词

nivolumab,lung cancer,long-term,health-related,previously-treated,non-small,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要